Clinical Trials Browser

Phase 4 × Interventional × Nausea × Clear all

NCT07038551 2025-07-02

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

Phase 4 Recruiting

Opioid-Induced Constipation, Constipation, Nausea, Vomiting

NCT06726291 2024-12-10

NOEME

Phase 4 Recruiting

Nausea, Vomiting, Endometrial Neoplasms

NCT03639415 2021-03-08

Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain

Phase 4 Withdrawn

Cancer Pain, Dizziness, Nausea, Pain, Intractable, Vomiting

NCT00588835 2020-11-30

ACE

Phase 4 Terminated

Nausea, Neoplasms

NCT01636947 2018-09-25

KMEC

Phase 4 Completed

494 enrolled 14 charts

Nausea, Neoplasms, Vomiting

NCT00684463 2017-05-16

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00687011 2017-05-15

Palonosetron Plus Dexamethasone in Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04594)

Phase 4 Completed

Nausea, Neoplasms, Vomiting

NCT00092183 2017-05-05

An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)

Phase 4 Completed

Breast Neoplasms, Nausea, Vomiting

NCT01913990 2017-01-30

ER11-02

Phase 4 Unknown

Nausea, Vomiting

NCT03017391 2017-01-11

Treatment Algorithm for Nausea and Vomiting in the Palliative Phase

Phase 4 Unknown

Nausea, Neoplasms, Vomiting

NCT00415103 2009-09-18

AMENO-2

Phase 4 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

NCT00158041 2005-09-12

Subcutaneous Amifostine Safety Study

Phase 4 Completed

Head & NeckLymphoidOtherThoracic

Exanthema, Head and Neck Neoplasms, Hypotension, Lung Neoplasms, Lymphoma, Nausea, Mucositis